Info
- Utilizzare la checkbox di selezione a fianco di ciascun documento per attivare le funzionalità di stampa, invio email, download nei formati disponibili del (i) record.
Adopting new medical technology [[electronic resource] /] / Annetine C. Gelijns and Holly V. Dawkins, editors ; Committee on Technological Innovation in Medicine, Institute of Medicine
| Adopting new medical technology [[electronic resource] /] / Annetine C. Gelijns and Holly V. Dawkins, editors ; Committee on Technological Innovation in Medicine, Institute of Medicine |
| Pubbl/distr/stampa | Washington, D.C., : National Academy Press, 1994 |
| Descrizione fisica | 1 online resource (240 p.) |
| Disciplina | 610 |
| Altri autori (Persone) |
GelijnsAnnetine
DawkinsHolly V |
| Collana | Medical innovation at the crossroads |
| Soggetto topico |
Medical innovations
Health insurance - United States Social medicine - United States Health care reform - United States |
| Soggetto genere / forma | Electronic books. |
| ISBN |
1-280-21121-0
9786610211210 0-309-58641-0 0-585-00175-8 |
| Formato | Materiale a stampa  |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Nota di contenuto |
""Adopting New Medical Technology""; ""Copyright""; ""Acknowledgments""; ""Contents""; ""PART I Setting the Stage""; ""1 Introduction ""; ""REFERENCES""; ""2 The Nature of Technological Change: Incentives Matter! ""; ""INTRODUCTION""; ""A BRIEF RECENT HISTORY OF HEALTH CARE IN THE UNITED STATES: TECHNOLOGICAL CHANGE AND THE GROWTH OF...""; ""DEFINING ""HEALTH CARE""""; ""EFFECTS OF RESEARCH AND DEVELOPMENT (TECHNOLOGICAL CHANGE) ON THE HEALTH CARE INSURANCE SYSTEM""; ""EFFECTS OF THE INSURANCE/FINANCE SYSTEM ON RESEARCH AND DEVELOPMENT""
""EFFECTS OF INSURANCE ON CHOICE OF TECHNOLOGY AND QUALITY OF HEALTH CARE IN THE SHORT RUN, WITH TECHN...""""CONCLUDING REMARKS""; ""REFERENCES""; ""3 The Impact of Technology Assessment on Decisions by Health Care Providers and Payers ""; ""OBJECTIVE""; ""METHODOLOGY""; ""RESULTS""; ""DISCUSSION""; ""Quality Issues""; ""Individual Skill Levels in Technology Assessment Vary Widely""; ""Technology Assessment Research is Expensive""; ""Timely Technology Assessment Information is Scarce""; ""Scope Issues""; ""Future Issues""; ""Education""; ""Financial Support""; ""Information""; ""REFERENCES"" ""PART II Provider Decisionmaking """"4 Role of the Hospital in the Acquisition of Technology ""; ""THE CHANGING FINANCIAL ENVIRONMENT""; ""MODELS OF HOSPITAL BEHAVIOR""; ""TECHNOLOGY ASSESSMENT: SOCIETAL VERSUS HOSPITAL PERSPECTIVE""; ""Societal Versus Hospital Perspective: Some Examples""; ""POLICY CONSIDERATIONS""; ""CONCLUSION""; ""REFERENCES""; ""5 Physicians' Decisions Regarding the Acquisition of Technology ""; ""INCENTIVES FOR THE ADOPTION OF MEDICAL INNOVATIONS""; ""CONCEPTUAL MODEL""; ""Innovation Characteristics""; ""Provider Characteristics""; ""Knowledge""; ""Awareness"" ""Judgment""""Trial""; ""Adoption""; ""Evaluation""; ""SUMMARY""; ""REFERENCES""; ""PART III Third Party Payer Coverage Decisions""; ""6 Decisionmaking in the Health Care Financing Administration ""; ""BACKGROUND ON MEDICARE COVERAGE""; ""PROBLEMS WITH THIS APPROACH""; ""PAYMENT CHANGES""; ""TOWARD A MORE REASONABLE COVERAGE APPROACH""; ""CONCLUSION""; ""REFERENCES""; ""7 Blue Cross and Blue Shield Association Initiatives in Technology Assessment ""; ""TECHNOLOGY ASSESSMENT""; ""Recent Changes to Program""; ""THE DEMONSTRATION PROJECT ON BREAST CANCER TREATMENT""; ""FUTURE DIRECTIONS"" ""REFERENCES""""8 Kaiser Permanente's New Technology Committee: Coverage Decisionmaking in a Group Model Health Mai...""; ""THE KAISER PERMANENTE PROGRAM""; ""THE NEW TECHNOLOGY COMMITTEE""; ""CATEGORIES OF NEW TECHNOLOGIES""; ""COSTS OF NEW TECHNOLOGIES""; ""Research Done by the Committee""; ""FACTORS AFFECTING DECISIONMAKING""; ""Experimental Exclusions""; ""CONCLUSION""; ""9 Autologous Bone Marrow Transplantation: A Microcosm of the U.S. Health Care System""; ""THE CONTROVERSY SURROUNDING HDC-ABMT""; ""OUTCOMES-BASED DECISIONMAKING""; ""PAYER PERSPECTIVE""; ""PROPOSAL""; ""RATIONALE"" ""DISCUSSION"" |
| Record Nr. | UNINA-9910455929003321 |
| Washington, D.C., : National Academy Press, 1994 | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
Adopting new medical technology [[electronic resource] /] / Annetine C. Gelijns and Holly V. Dawkins, editors ; Committee on Technological Innovation in Medicine, Institute of Medicine
| Adopting new medical technology [[electronic resource] /] / Annetine C. Gelijns and Holly V. Dawkins, editors ; Committee on Technological Innovation in Medicine, Institute of Medicine |
| Pubbl/distr/stampa | Washington, D.C., : National Academy Press, 1994 |
| Descrizione fisica | 1 online resource (240 p.) |
| Disciplina | 610 |
| Altri autori (Persone) |
GelijnsAnnetine
DawkinsHolly V |
| Collana | Medical innovation at the crossroads |
| Soggetto topico |
Medical innovations
Health insurance - United States Social medicine - United States Health care reform - United States |
| ISBN |
1-280-21121-0
9786610211210 0-309-58641-0 0-585-00175-8 |
| Formato | Materiale a stampa |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Nota di contenuto |
""Adopting New Medical Technology""; ""Copyright""; ""Acknowledgments""; ""Contents""; ""PART I Setting the Stage""; ""1 Introduction ""; ""REFERENCES""; ""2 The Nature of Technological Change: Incentives Matter! ""; ""INTRODUCTION""; ""A BRIEF RECENT HISTORY OF HEALTH CARE IN THE UNITED STATES: TECHNOLOGICAL CHANGE AND THE GROWTH OF...""; ""DEFINING ""HEALTH CARE""""; ""EFFECTS OF RESEARCH AND DEVELOPMENT (TECHNOLOGICAL CHANGE) ON THE HEALTH CARE INSURANCE SYSTEM""; ""EFFECTS OF THE INSURANCE/FINANCE SYSTEM ON RESEARCH AND DEVELOPMENT""
""EFFECTS OF INSURANCE ON CHOICE OF TECHNOLOGY AND QUALITY OF HEALTH CARE IN THE SHORT RUN, WITH TECHN...""""CONCLUDING REMARKS""; ""REFERENCES""; ""3 The Impact of Technology Assessment on Decisions by Health Care Providers and Payers ""; ""OBJECTIVE""; ""METHODOLOGY""; ""RESULTS""; ""DISCUSSION""; ""Quality Issues""; ""Individual Skill Levels in Technology Assessment Vary Widely""; ""Technology Assessment Research is Expensive""; ""Timely Technology Assessment Information is Scarce""; ""Scope Issues""; ""Future Issues""; ""Education""; ""Financial Support""; ""Information""; ""REFERENCES"" ""PART II Provider Decisionmaking """"4 Role of the Hospital in the Acquisition of Technology ""; ""THE CHANGING FINANCIAL ENVIRONMENT""; ""MODELS OF HOSPITAL BEHAVIOR""; ""TECHNOLOGY ASSESSMENT: SOCIETAL VERSUS HOSPITAL PERSPECTIVE""; ""Societal Versus Hospital Perspective: Some Examples""; ""POLICY CONSIDERATIONS""; ""CONCLUSION""; ""REFERENCES""; ""5 Physicians' Decisions Regarding the Acquisition of Technology ""; ""INCENTIVES FOR THE ADOPTION OF MEDICAL INNOVATIONS""; ""CONCEPTUAL MODEL""; ""Innovation Characteristics""; ""Provider Characteristics""; ""Knowledge""; ""Awareness"" ""Judgment""""Trial""; ""Adoption""; ""Evaluation""; ""SUMMARY""; ""REFERENCES""; ""PART III Third Party Payer Coverage Decisions""; ""6 Decisionmaking in the Health Care Financing Administration ""; ""BACKGROUND ON MEDICARE COVERAGE""; ""PROBLEMS WITH THIS APPROACH""; ""PAYMENT CHANGES""; ""TOWARD A MORE REASONABLE COVERAGE APPROACH""; ""CONCLUSION""; ""REFERENCES""; ""7 Blue Cross and Blue Shield Association Initiatives in Technology Assessment ""; ""TECHNOLOGY ASSESSMENT""; ""Recent Changes to Program""; ""THE DEMONSTRATION PROJECT ON BREAST CANCER TREATMENT""; ""FUTURE DIRECTIONS"" ""REFERENCES""""8 Kaiser Permanente's New Technology Committee: Coverage Decisionmaking in a Group Model Health Mai...""; ""THE KAISER PERMANENTE PROGRAM""; ""THE NEW TECHNOLOGY COMMITTEE""; ""CATEGORIES OF NEW TECHNOLOGIES""; ""COSTS OF NEW TECHNOLOGIES""; ""Research Done by the Committee""; ""FACTORS AFFECTING DECISIONMAKING""; ""Experimental Exclusions""; ""CONCLUSION""; ""9 Autologous Bone Marrow Transplantation: A Microcosm of the U.S. Health Care System""; ""THE CONTROVERSY SURROUNDING HDC-ABMT""; ""OUTCOMES-BASED DECISIONMAKING""; ""PAYER PERSPECTIVE""; ""PROPOSAL""; ""RATIONALE"" ""DISCUSSION"" |
| Record Nr. | UNINA-9910778772503321 |
| Washington, D.C., : National Academy Press, 1994 | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
Adopting new medical technology / / Annetine C. Gelijns and Holly V. Dawkins, editors ; Committee on Technological Innovation in Medicine, Institute of Medicine
| Adopting new medical technology / / Annetine C. Gelijns and Holly V. Dawkins, editors ; Committee on Technological Innovation in Medicine, Institute of Medicine |
| Edizione | [1st ed.] |
| Pubbl/distr/stampa | Washington, D.C., : National Academy Press, 1994 |
| Descrizione fisica | 1 online resource (240 p.) |
| Disciplina | 610 |
| Altri autori (Persone) |
GelijnsAnnetine
DawkinsHolly V |
| Collana | Medical innovation at the crossroads |
| Soggetto topico |
Medical innovations
Health insurance - United States Social medicine - United States Health care reform - United States |
| ISBN |
9786610211210
9781280211218 1280211210 9780309586412 0309586410 9780585001753 0585001758 |
| Formato | Materiale a stampa |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Nota di contenuto |
""Adopting New Medical Technology""; ""Copyright""; ""Acknowledgments""; ""Contents""; ""PART I Setting the Stage""; ""1 Introduction ""; ""REFERENCES""; ""2 The Nature of Technological Change: Incentives Matter! ""; ""INTRODUCTION""; ""A BRIEF RECENT HISTORY OF HEALTH CARE IN THE UNITED STATES: TECHNOLOGICAL CHANGE AND THE GROWTH OF...""; ""DEFINING ""HEALTH CARE""""; ""EFFECTS OF RESEARCH AND DEVELOPMENT (TECHNOLOGICAL CHANGE) ON THE HEALTH CARE INSURANCE SYSTEM""; ""EFFECTS OF THE INSURANCE/FINANCE SYSTEM ON RESEARCH AND DEVELOPMENT""
""EFFECTS OF INSURANCE ON CHOICE OF TECHNOLOGY AND QUALITY OF HEALTH CARE IN THE SHORT RUN, WITH TECHN...""""CONCLUDING REMARKS""; ""REFERENCES""; ""3 The Impact of Technology Assessment on Decisions by Health Care Providers and Payers ""; ""OBJECTIVE""; ""METHODOLOGY""; ""RESULTS""; ""DISCUSSION""; ""Quality Issues""; ""Individual Skill Levels in Technology Assessment Vary Widely""; ""Technology Assessment Research is Expensive""; ""Timely Technology Assessment Information is Scarce""; ""Scope Issues""; ""Future Issues""; ""Education""; ""Financial Support""; ""Information""; ""REFERENCES"" ""PART II Provider Decisionmaking """"4 Role of the Hospital in the Acquisition of Technology ""; ""THE CHANGING FINANCIAL ENVIRONMENT""; ""MODELS OF HOSPITAL BEHAVIOR""; ""TECHNOLOGY ASSESSMENT: SOCIETAL VERSUS HOSPITAL PERSPECTIVE""; ""Societal Versus Hospital Perspective: Some Examples""; ""POLICY CONSIDERATIONS""; ""CONCLUSION""; ""REFERENCES""; ""5 Physicians' Decisions Regarding the Acquisition of Technology ""; ""INCENTIVES FOR THE ADOPTION OF MEDICAL INNOVATIONS""; ""CONCEPTUAL MODEL""; ""Innovation Characteristics""; ""Provider Characteristics""; ""Knowledge""; ""Awareness"" ""Judgment""""Trial""; ""Adoption""; ""Evaluation""; ""SUMMARY""; ""REFERENCES""; ""PART III Third Party Payer Coverage Decisions""; ""6 Decisionmaking in the Health Care Financing Administration ""; ""BACKGROUND ON MEDICARE COVERAGE""; ""PROBLEMS WITH THIS APPROACH""; ""PAYMENT CHANGES""; ""TOWARD A MORE REASONABLE COVERAGE APPROACH""; ""CONCLUSION""; ""REFERENCES""; ""7 Blue Cross and Blue Shield Association Initiatives in Technology Assessment ""; ""TECHNOLOGY ASSESSMENT""; ""Recent Changes to Program""; ""THE DEMONSTRATION PROJECT ON BREAST CANCER TREATMENT""; ""FUTURE DIRECTIONS"" ""REFERENCES""""8 Kaiser Permanente's New Technology Committee: Coverage Decisionmaking in a Group Model Health Mai...""; ""THE KAISER PERMANENTE PROGRAM""; ""THE NEW TECHNOLOGY COMMITTEE""; ""CATEGORIES OF NEW TECHNOLOGIES""; ""COSTS OF NEW TECHNOLOGIES""; ""Research Done by the Committee""; ""FACTORS AFFECTING DECISIONMAKING""; ""Experimental Exclusions""; ""CONCLUSION""; ""9 Autologous Bone Marrow Transplantation: A Microcosm of the U.S. Health Care System""; ""THE CONTROVERSY SURROUNDING HDC-ABMT""; ""OUTCOMES-BASED DECISIONMAKING""; ""PAYER PERSPECTIVE""; ""PROPOSAL""; ""RATIONALE"" ""DISCUSSION"" |
| Record Nr. | UNINA-9910965599603321 |
| Washington, D.C., : National Academy Press, 1994 | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
The Changing economics of medical technology [[electronic resource] /] / Annetine C. Gelijns and Ethan A. Halm, editors ; Committee on Technological Innovation in Medicine, Institute of Medicine
| The Changing economics of medical technology [[electronic resource] /] / Annetine C. Gelijns and Ethan A. Halm, editors ; Committee on Technological Innovation in Medicine, Institute of Medicine |
| Pubbl/distr/stampa | Washington, D.C., : National Academy Press, 1991 |
| Descrizione fisica | 1 online resource (224 p.) |
| Disciplina | 338.43/61/028 |
| Altri autori (Persone) |
GelijnsAnnetine
HalmEthan A |
| Collana | Medical innovation at the crossroads |
| Soggetto topico |
Medical innovations - Economic aspects
Pharmaceutical industry - Technological innovations - Economic aspects |
| Soggetto genere / forma | Electronic books. |
| ISBN |
1-280-20362-5
9786610203628 0-309-55594-9 0-585-17750-3 |
| Formato | Materiale a stampa |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Nota di contenuto |
""The Changing Economics of Medical Technology""; ""Copyright""; ""Acknowledgments""; ""Preface""; ""Contents""; ""List of Abbreviations""; ""1 An Introduction to the Changing Economics of Technological Innovation in Medicine ""; ""A DYNAMIC MODEL OF TECHNOLOGICAL INNOVATION IN MEDICINE""; ""THE DYNAMICS OF PHARMACEUTICAL INNOVATION""; ""THE DYNAMICS OF DEVICE INNOVATION""; ""THE DYNAMICS OF SURGICAL INNOVATION""; ""INTERNATIONAL COMPARISONS: EUROPE AND JAPAN""; ""CONCLUDING OBSERVATIONS""; ""NOTES""; ""REFERENCES""; ""2 The Diffusion of New Technology: Costs and Benefits to Health Care ""
""HOW MUCH DOES NEW TECHNOLOGY ADD TO HEALTH CARE COSTS?""""OPTIMAL DIFFUSION OF TECHNOLOGY: THE COST-EFFECTIVENESS PRINCIPLE""; ""EFFECTS OF REIMBURSEMENT ON THE USE OF NEW TECHNOLOGIES""; ""Hospitals""; ""HMOs and Managed Care Plans""; ""Incentives for Fee-for-Service Physicians""; ""FUTURE DIRECTIONS: HOW TO ACHIEVE COST-EFFECTIVE DIFFUSION OF MEDICAL TECHNOLOGY""; ""NOTE""; ""REFERENCES""; ""3 The Changing Economics of Pharmaceutical Research and Development ""; ""CURRENT TRENDS""; ""R&D Opportunities""; ""R&D Costs""; ""Product Life Cycles""; ""Effective Patent Life""; ""Drug Prices"" ""RETURN TO PHARMACEUTICAL R&D""""IMPLICATIONS""; ""PUBLIC POLICY CONSIDERATIONS""; ""NOTES""; ""REFERENCES""; ""4 Public Policy and Access to New Drugs: The Case of Cancer Chemotherapy ""; ""CANCER CARE: A SERIES OF INCREMENTAL INNOVATIONS""; ""A PERIOD OF TRANSITION: FROM RAPID GROWTH TO STRICT CONTROL""; ""REIMBURSEMENT POLICIES AND THEIR EFFECT ON THE USE OF NEW TECHNOLOGIES""; ""The Effects of the Prospective Payment System""; ""The Dis-Integration of Care""; ""Growing Patterns of Denial of Payment""; ""Off-Label Use and New Indications""; ""Payment for Investigational Therapies"" ""EFFECTS OF REIMBURSEMENT POLICIES ON INNOVATION""""The Impact of the PPS on Clinical Research""; ""Decreasing Effective Patent Life""; ""GROWING DISINCENTIVES TO PROVIDING STATE-OF-THE-ART CARE""; ""PROSPECTS FOR THE FUTURE""; ""NOTE""; ""REFERENCES""; ""5 The Impact of Public Policy on Medical Device Innovation: A Case of Polyintervention ""; ""THE ASSESSMENT: PUBLIC POLICIES AND MEDICAL DEVICE INNOVATION""; ""The Limits of the Traditional Models of Innovation""; ""The Pivotal Role of Public Policy""; ""THE MEDICAL DEVICE INDUSTRY AS PATIENT"" ""THE EVALUATION: THE IMPACT OF POLYINTERVENTION""""Case Study: Lithotripsy""; ""Case Study: Intraocular Lenses""; ""TREATMENT OPTIONS: IMPROVING THE PUBLIC POLICY ENVIRONMENT""; ""Fine-tuning Individual Policies""; ""Understanding Polyintervention""; ""CONCLUSION""; ""NOTE""; ""REFERENCES""; ""6 The Dynamics of Medical Device Innovation: An Innovator's Perspective ""; ""PATENTS""; ""WHO DOES R&D?""; ""FINANCING OF INNOVATION""; ""REGULATORY DIFFERENCES""; ""THE ROLE OF LIABILITY""; ""REIMBURSEMENT""; ""CONCLUSIONS""; ""SELECTIVE BIBLIOGRAPHY"" ""7 Reimbursement and the Dynamics of Surgical Procedure Innovation "" |
| Record Nr. | UNINA-9910454870903321 |
| Washington, D.C., : National Academy Press, 1991 | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
The Changing economics of medical technology [[electronic resource] /] / Annetine C. Gelijns and Ethan A. Halm, editors ; Committee on Technological Innovation in Medicine, Institute of Medicine
| The Changing economics of medical technology [[electronic resource] /] / Annetine C. Gelijns and Ethan A. Halm, editors ; Committee on Technological Innovation in Medicine, Institute of Medicine |
| Pubbl/distr/stampa | Washington, D.C., : National Academy Press, 1991 |
| Descrizione fisica | 1 online resource (224 p.) |
| Disciplina | 338.43/61/028 |
| Altri autori (Persone) |
GelijnsAnnetine
HalmEthan A |
| Collana | Medical innovation at the crossroads |
| Soggetto topico |
Medical innovations - Economic aspects
Pharmaceutical industry - Technological innovations - Economic aspects |
| ISBN |
1-280-20362-5
9786610203628 0-309-55594-9 0-585-17750-3 |
| Formato | Materiale a stampa |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Nota di contenuto |
""The Changing Economics of Medical Technology""; ""Copyright""; ""Acknowledgments""; ""Preface""; ""Contents""; ""List of Abbreviations""; ""1 An Introduction to the Changing Economics of Technological Innovation in Medicine ""; ""A DYNAMIC MODEL OF TECHNOLOGICAL INNOVATION IN MEDICINE""; ""THE DYNAMICS OF PHARMACEUTICAL INNOVATION""; ""THE DYNAMICS OF DEVICE INNOVATION""; ""THE DYNAMICS OF SURGICAL INNOVATION""; ""INTERNATIONAL COMPARISONS: EUROPE AND JAPAN""; ""CONCLUDING OBSERVATIONS""; ""NOTES""; ""REFERENCES""; ""2 The Diffusion of New Technology: Costs and Benefits to Health Care ""
""HOW MUCH DOES NEW TECHNOLOGY ADD TO HEALTH CARE COSTS?""""OPTIMAL DIFFUSION OF TECHNOLOGY: THE COST-EFFECTIVENESS PRINCIPLE""; ""EFFECTS OF REIMBURSEMENT ON THE USE OF NEW TECHNOLOGIES""; ""Hospitals""; ""HMOs and Managed Care Plans""; ""Incentives for Fee-for-Service Physicians""; ""FUTURE DIRECTIONS: HOW TO ACHIEVE COST-EFFECTIVE DIFFUSION OF MEDICAL TECHNOLOGY""; ""NOTE""; ""REFERENCES""; ""3 The Changing Economics of Pharmaceutical Research and Development ""; ""CURRENT TRENDS""; ""R&D Opportunities""; ""R&D Costs""; ""Product Life Cycles""; ""Effective Patent Life""; ""Drug Prices"" ""RETURN TO PHARMACEUTICAL R&D""""IMPLICATIONS""; ""PUBLIC POLICY CONSIDERATIONS""; ""NOTES""; ""REFERENCES""; ""4 Public Policy and Access to New Drugs: The Case of Cancer Chemotherapy ""; ""CANCER CARE: A SERIES OF INCREMENTAL INNOVATIONS""; ""A PERIOD OF TRANSITION: FROM RAPID GROWTH TO STRICT CONTROL""; ""REIMBURSEMENT POLICIES AND THEIR EFFECT ON THE USE OF NEW TECHNOLOGIES""; ""The Effects of the Prospective Payment System""; ""The Dis-Integration of Care""; ""Growing Patterns of Denial of Payment""; ""Off-Label Use and New Indications""; ""Payment for Investigational Therapies"" ""EFFECTS OF REIMBURSEMENT POLICIES ON INNOVATION""""The Impact of the PPS on Clinical Research""; ""Decreasing Effective Patent Life""; ""GROWING DISINCENTIVES TO PROVIDING STATE-OF-THE-ART CARE""; ""PROSPECTS FOR THE FUTURE""; ""NOTE""; ""REFERENCES""; ""5 The Impact of Public Policy on Medical Device Innovation: A Case of Polyintervention ""; ""THE ASSESSMENT: PUBLIC POLICIES AND MEDICAL DEVICE INNOVATION""; ""The Limits of the Traditional Models of Innovation""; ""The Pivotal Role of Public Policy""; ""THE MEDICAL DEVICE INDUSTRY AS PATIENT"" ""THE EVALUATION: THE IMPACT OF POLYINTERVENTION""""Case Study: Lithotripsy""; ""Case Study: Intraocular Lenses""; ""TREATMENT OPTIONS: IMPROVING THE PUBLIC POLICY ENVIRONMENT""; ""Fine-tuning Individual Policies""; ""Understanding Polyintervention""; ""CONCLUSION""; ""NOTE""; ""REFERENCES""; ""6 The Dynamics of Medical Device Innovation: An Innovator's Perspective ""; ""PATENTS""; ""WHO DOES R&D?""; ""FINANCING OF INNOVATION""; ""REGULATORY DIFFERENCES""; ""THE ROLE OF LIABILITY""; ""REIMBURSEMENT""; ""CONCLUSIONS""; ""SELECTIVE BIBLIOGRAPHY"" ""7 Reimbursement and the Dynamics of Surgical Procedure Innovation "" |
| Record Nr. | UNINA-9910778876303321 |
| Washington, D.C., : National Academy Press, 1991 | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
The Changing economics of medical technology / / Annetine C. Gelijns and Ethan A. Halm, editors ; Committee on Technological Innovation in Medicine, Institute of Medicine
| The Changing economics of medical technology / / Annetine C. Gelijns and Ethan A. Halm, editors ; Committee on Technological Innovation in Medicine, Institute of Medicine |
| Edizione | [1st ed.] |
| Pubbl/distr/stampa | Washington, D.C., : National Academy Press, 1991 |
| Descrizione fisica | 1 online resource (224 p.) |
| Disciplina | 338.43/61/028 |
| Altri autori (Persone) |
GelijnsAnnetine
HalmEthan A |
| Collana | Medical innovation at the crossroads |
| Soggetto topico |
Medical innovations - Economic aspects
Pharmaceutical industry - Technological innovations - Economic aspects |
| ISBN |
9786610203628
9781280203626 1280203625 9780309555944 0309555949 9780585177502 0585177503 |
| Formato | Materiale a stampa |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Nota di contenuto |
""The Changing Economics of Medical Technology""; ""Copyright""; ""Acknowledgments""; ""Preface""; ""Contents""; ""List of Abbreviations""; ""1 An Introduction to the Changing Economics of Technological Innovation in Medicine ""; ""A DYNAMIC MODEL OF TECHNOLOGICAL INNOVATION IN MEDICINE""; ""THE DYNAMICS OF PHARMACEUTICAL INNOVATION""; ""THE DYNAMICS OF DEVICE INNOVATION""; ""THE DYNAMICS OF SURGICAL INNOVATION""; ""INTERNATIONAL COMPARISONS: EUROPE AND JAPAN""; ""CONCLUDING OBSERVATIONS""; ""NOTES""; ""REFERENCES""; ""2 The Diffusion of New Technology: Costs and Benefits to Health Care ""
""HOW MUCH DOES NEW TECHNOLOGY ADD TO HEALTH CARE COSTS?""""OPTIMAL DIFFUSION OF TECHNOLOGY: THE COST-EFFECTIVENESS PRINCIPLE""; ""EFFECTS OF REIMBURSEMENT ON THE USE OF NEW TECHNOLOGIES""; ""Hospitals""; ""HMOs and Managed Care Plans""; ""Incentives for Fee-for-Service Physicians""; ""FUTURE DIRECTIONS: HOW TO ACHIEVE COST-EFFECTIVE DIFFUSION OF MEDICAL TECHNOLOGY""; ""NOTE""; ""REFERENCES""; ""3 The Changing Economics of Pharmaceutical Research and Development ""; ""CURRENT TRENDS""; ""R&D Opportunities""; ""R&D Costs""; ""Product Life Cycles""; ""Effective Patent Life""; ""Drug Prices"" ""RETURN TO PHARMACEUTICAL R&D""""IMPLICATIONS""; ""PUBLIC POLICY CONSIDERATIONS""; ""NOTES""; ""REFERENCES""; ""4 Public Policy and Access to New Drugs: The Case of Cancer Chemotherapy ""; ""CANCER CARE: A SERIES OF INCREMENTAL INNOVATIONS""; ""A PERIOD OF TRANSITION: FROM RAPID GROWTH TO STRICT CONTROL""; ""REIMBURSEMENT POLICIES AND THEIR EFFECT ON THE USE OF NEW TECHNOLOGIES""; ""The Effects of the Prospective Payment System""; ""The Dis-Integration of Care""; ""Growing Patterns of Denial of Payment""; ""Off-Label Use and New Indications""; ""Payment for Investigational Therapies"" ""EFFECTS OF REIMBURSEMENT POLICIES ON INNOVATION""""The Impact of the PPS on Clinical Research""; ""Decreasing Effective Patent Life""; ""GROWING DISINCENTIVES TO PROVIDING STATE-OF-THE-ART CARE""; ""PROSPECTS FOR THE FUTURE""; ""NOTE""; ""REFERENCES""; ""5 The Impact of Public Policy on Medical Device Innovation: A Case of Polyintervention ""; ""THE ASSESSMENT: PUBLIC POLICIES AND MEDICAL DEVICE INNOVATION""; ""The Limits of the Traditional Models of Innovation""; ""The Pivotal Role of Public Policy""; ""THE MEDICAL DEVICE INDUSTRY AS PATIENT"" ""THE EVALUATION: THE IMPACT OF POLYINTERVENTION""""Case Study: Lithotripsy""; ""Case Study: Intraocular Lenses""; ""TREATMENT OPTIONS: IMPROVING THE PUBLIC POLICY ENVIRONMENT""; ""Fine-tuning Individual Policies""; ""Understanding Polyintervention""; ""CONCLUSION""; ""NOTE""; ""REFERENCES""; ""6 The Dynamics of Medical Device Innovation: An Innovator's Perspective ""; ""PATENTS""; ""WHO DOES R&D?""; ""FINANCING OF INNOVATION""; ""REGULATORY DIFFERENCES""; ""THE ROLE OF LIABILITY""; ""REIMBURSEMENT""; ""CONCLUSIONS""; ""SELECTIVE BIBLIOGRAPHY"" ""7 Reimbursement and the Dynamics of Surgical Procedure Innovation "" |
| Record Nr. | UNINA-9910953846103321 |
| Washington, D.C., : National Academy Press, 1991 | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
Modern methods of clinical investigation [[electronic resource] /] / Annetine C. Gelijns, editor ; Committee on Technological Innovation in Medicine, Institute of Medicine
| Modern methods of clinical investigation [[electronic resource] /] / Annetine C. Gelijns, editor ; Committee on Technological Innovation in Medicine, Institute of Medicine |
| Pubbl/distr/stampa | Washington, D.C., : National Academy Press, 1990 |
| Descrizione fisica | 1 online resource (244 p.) |
| Disciplina | 610/.72 |
| Altri autori (Persone) | GelijnsAnnetine |
| Collana | Medical innovation at the crossroads |
| Soggetto topico |
Medical technology - Evaluation
Medical innovations - Evaluation Medical care - Technological innovations Meta-analysis |
| Soggetto genere / forma | Electronic books. |
| ISBN |
1-280-21225-X
9786610212255 0-309-54356-8 0-585-12524-4 |
| Formato | Materiale a stampa |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Nota di contenuto |
""Modern Methods of Clinical Investigation""; ""Copyright""; ""Acknowledgments""; ""Preface""; ""Contents""; ""List of Abbreviations""; ""1 Medical Technology Development: An Introduction to the Innovation-Evaluation Nexus ""; ""PUTTING CLINICAL EVALUATION IN CONTEXT""; ""ISSUES IN INNOVATION AND EVALUATION: THE CASE OF STABLE ANGINA PECTORIS""; ""Beta-Blockers""; ""Coronary Artery Bypass Grafting""; ""PTCA Catheter Equipment""; ""Evaluative Shortcomings in Technology Development""; ""IMPROVING THE INNOVATION-EVALUATION NEXUS""; ""The Selection of Endpoints in Evaluative Research""
""The Selection of Methods for Clinical Investigation""""Policy Mechanisms for Improving Developmental Decision Making""; ""REFERENCES""; ""2 The Selection of Endpoints in Evaluative Research ""; ""SURROGATE VERSUS CLINICAL ENDPOINTS""; ""CLINICAL ENDPOINTS""; ""SURROGATE ENDPOINTS""; ""REFERENCES""; ""3 Advances in Health Status Measurement: The Potential to Improve Experimental and Non-Experimental Data Collection""; ""THE CONDUCT OF CLINICAL TRIALS""; ""MEASUREMENT OF QUALITY OF LIFE AND OF HEALTH STATUS""; ""INCLUSION OF QUALITY OF LIFE AND HEALTH STATUS MEASURES IN CLINICAL TRIALS"" ""FOUR PROBLEMS REGARDING THE MEASUREMENT OF HEALTH STATUS IN CLINICAL TRIALS""""REFERENCES""; ""4 What Is Outcomes Research? ""; ""WHICH RATE IS RIGHT?""; ""ENGAGING PATIENTS IN THE DECISION PROCESS""; ""EXTENDING ASSESSMENT TO ALL RELEVANT TREATMENT THEORIES""; ""THE EVALUATIVE CLINICAL SCIENCES AND THE FUTURE OF MEDICINE""; ""REFERENCES""; ""5 Strengths and Weaknesses of Health Insurance Data Systems for Assessing Outcomes""; ""STRENGTHS""; ""System-Wide, Population-Based Data""; ""Efficacy versus Effectiveness""; ""Large Numbers and Time Series""; ""Events Unaffected by Recall"" ""Unobtrusive Nature""""Multiple Comparisons""; ""Design Flexibility""; ""Potential for Multiple Projects""; ""Focus on Risks""; ""Clinical Decision Making""; ""WEAKNESSES""; ""Structural Limitations""; ""Bias Due to Reporting and Coding""; ""Bias Due to Differential Contact""; ""Benefits of Treatment""; ""CONTROVERSIAL AREAS""; ""Risk Adjustment""; ""Outcome Measures""; ""EXPANDING DATA BASES""; ""Record Linkage""; ""Primary Data Collection""; ""DISCUSSION""; ""REFERENCES""; ""6 Prescription-Event Monitoring: An Example of Total Population Post-Marketing Drug Surveillance "" """"THE NUMBERS GAME""""""VOLUNTARY REPORTING SYSTEMS""; ""POST-MARKETING SURVEILLANCE""; ""PRESCRIPTION-EVENT MONITORING""; ""COMPARATIVE STUDIES OF NSAIDS""; ""POST-MARKETING SURVEILLANCE AND POST-MARKETING CLINICAL TRIALS""; ""CONCLUSION""; ""REFERENCES""; ""7 The Role of Decision Analysis in the Translation of Research Findings into Clinical Practice ""; ""DECISION ANALYSIS AT THE INTERFACE BETWEEN CLINICAL INVESTIGATION AND CLINICAL PRACTICE""; ""WHAT DECISION ANALYSIS IS""; ""THE LIMITATIONS OF DECISION ANALYSIS: WHAT IT IS NOT"" ""SETTING PRIORITIES AND PARAMETERS FOR CLINICAL INVESTIGATION"" |
| Record Nr. | UNINA-9910455143003321 |
| Washington, D.C., : National Academy Press, 1990 | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
Modern methods of clinical investigation [[electronic resource] /] / Annetine C. Gelijns, editor ; Committee on Technological Innovation in Medicine, Institute of Medicine
| Modern methods of clinical investigation [[electronic resource] /] / Annetine C. Gelijns, editor ; Committee on Technological Innovation in Medicine, Institute of Medicine |
| Pubbl/distr/stampa | Washington, D.C., : National Academy Press, 1990 |
| Descrizione fisica | 1 online resource (244 p.) |
| Disciplina | 610/.72 |
| Altri autori (Persone) | GelijnsAnnetine |
| Collana | Medical innovation at the crossroads |
| Soggetto topico |
Medical technology - Evaluation
Medical innovations - Evaluation Medical care - Technological innovations Meta-analysis |
| ISBN |
1-280-21225-X
9786610212255 0-309-54356-8 0-585-12524-4 |
| Formato | Materiale a stampa |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Nota di contenuto |
""Modern Methods of Clinical Investigation""; ""Copyright""; ""Acknowledgments""; ""Preface""; ""Contents""; ""List of Abbreviations""; ""1 Medical Technology Development: An Introduction to the Innovation-Evaluation Nexus ""; ""PUTTING CLINICAL EVALUATION IN CONTEXT""; ""ISSUES IN INNOVATION AND EVALUATION: THE CASE OF STABLE ANGINA PECTORIS""; ""Beta-Blockers""; ""Coronary Artery Bypass Grafting""; ""PTCA Catheter Equipment""; ""Evaluative Shortcomings in Technology Development""; ""IMPROVING THE INNOVATION-EVALUATION NEXUS""; ""The Selection of Endpoints in Evaluative Research""
""The Selection of Methods for Clinical Investigation""""Policy Mechanisms for Improving Developmental Decision Making""; ""REFERENCES""; ""2 The Selection of Endpoints in Evaluative Research ""; ""SURROGATE VERSUS CLINICAL ENDPOINTS""; ""CLINICAL ENDPOINTS""; ""SURROGATE ENDPOINTS""; ""REFERENCES""; ""3 Advances in Health Status Measurement: The Potential to Improve Experimental and Non-Experimental Data Collection""; ""THE CONDUCT OF CLINICAL TRIALS""; ""MEASUREMENT OF QUALITY OF LIFE AND OF HEALTH STATUS""; ""INCLUSION OF QUALITY OF LIFE AND HEALTH STATUS MEASURES IN CLINICAL TRIALS"" ""FOUR PROBLEMS REGARDING THE MEASUREMENT OF HEALTH STATUS IN CLINICAL TRIALS""""REFERENCES""; ""4 What Is Outcomes Research? ""; ""WHICH RATE IS RIGHT?""; ""ENGAGING PATIENTS IN THE DECISION PROCESS""; ""EXTENDING ASSESSMENT TO ALL RELEVANT TREATMENT THEORIES""; ""THE EVALUATIVE CLINICAL SCIENCES AND THE FUTURE OF MEDICINE""; ""REFERENCES""; ""5 Strengths and Weaknesses of Health Insurance Data Systems for Assessing Outcomes""; ""STRENGTHS""; ""System-Wide, Population-Based Data""; ""Efficacy versus Effectiveness""; ""Large Numbers and Time Series""; ""Events Unaffected by Recall"" ""Unobtrusive Nature""""Multiple Comparisons""; ""Design Flexibility""; ""Potential for Multiple Projects""; ""Focus on Risks""; ""Clinical Decision Making""; ""WEAKNESSES""; ""Structural Limitations""; ""Bias Due to Reporting and Coding""; ""Bias Due to Differential Contact""; ""Benefits of Treatment""; ""CONTROVERSIAL AREAS""; ""Risk Adjustment""; ""Outcome Measures""; ""EXPANDING DATA BASES""; ""Record Linkage""; ""Primary Data Collection""; ""DISCUSSION""; ""REFERENCES""; ""6 Prescription-Event Monitoring: An Example of Total Population Post-Marketing Drug Surveillance "" """"THE NUMBERS GAME""""""VOLUNTARY REPORTING SYSTEMS""; ""POST-MARKETING SURVEILLANCE""; ""PRESCRIPTION-EVENT MONITORING""; ""COMPARATIVE STUDIES OF NSAIDS""; ""POST-MARKETING SURVEILLANCE AND POST-MARKETING CLINICAL TRIALS""; ""CONCLUSION""; ""REFERENCES""; ""7 The Role of Decision Analysis in the Translation of Research Findings into Clinical Practice ""; ""DECISION ANALYSIS AT THE INTERFACE BETWEEN CLINICAL INVESTIGATION AND CLINICAL PRACTICE""; ""WHAT DECISION ANALYSIS IS""; ""THE LIMITATIONS OF DECISION ANALYSIS: WHAT IT IS NOT"" ""SETTING PRIORITIES AND PARAMETERS FOR CLINICAL INVESTIGATION"" |
| Record Nr. | UNINA-9910778703803321 |
| Washington, D.C., : National Academy Press, 1990 | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
Modern methods of clinical investigation / / Annetine C. Gelijns, editor ; Committee on Technological Innovation in Medicine, Institute of Medicine
| Modern methods of clinical investigation / / Annetine C. Gelijns, editor ; Committee on Technological Innovation in Medicine, Institute of Medicine |
| Edizione | [1st ed.] |
| Pubbl/distr/stampa | Washington, D.C., : National Academy Press, 1990 |
| Descrizione fisica | 1 online resource (244 p.) |
| Disciplina | 610/.72 |
| Altri autori (Persone) | GelijnsAnnetine |
| Collana | Medical innovation at the crossroads |
| Soggetto topico |
Medical technology - Evaluation
Medical innovations - Evaluation Medical care - Technological innovations Meta-analysis |
| ISBN |
9786610212255
9781280212253 128021225X 9780309543569 0309543568 9780585125244 0585125244 |
| Formato | Materiale a stampa |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Nota di contenuto |
""Modern Methods of Clinical Investigation""; ""Copyright""; ""Acknowledgments""; ""Preface""; ""Contents""; ""List of Abbreviations""; ""1 Medical Technology Development: An Introduction to the Innovation-Evaluation Nexus ""; ""PUTTING CLINICAL EVALUATION IN CONTEXT""; ""ISSUES IN INNOVATION AND EVALUATION: THE CASE OF STABLE ANGINA PECTORIS""; ""Beta-Blockers""; ""Coronary Artery Bypass Grafting""; ""PTCA Catheter Equipment""; ""Evaluative Shortcomings in Technology Development""; ""IMPROVING THE INNOVATION-EVALUATION NEXUS""; ""The Selection of Endpoints in Evaluative Research""
""The Selection of Methods for Clinical Investigation""""Policy Mechanisms for Improving Developmental Decision Making""; ""REFERENCES""; ""2 The Selection of Endpoints in Evaluative Research ""; ""SURROGATE VERSUS CLINICAL ENDPOINTS""; ""CLINICAL ENDPOINTS""; ""SURROGATE ENDPOINTS""; ""REFERENCES""; ""3 Advances in Health Status Measurement: The Potential to Improve Experimental and Non-Experimental Data Collection""; ""THE CONDUCT OF CLINICAL TRIALS""; ""MEASUREMENT OF QUALITY OF LIFE AND OF HEALTH STATUS""; ""INCLUSION OF QUALITY OF LIFE AND HEALTH STATUS MEASURES IN CLINICAL TRIALS"" ""FOUR PROBLEMS REGARDING THE MEASUREMENT OF HEALTH STATUS IN CLINICAL TRIALS""""REFERENCES""; ""4 What Is Outcomes Research? ""; ""WHICH RATE IS RIGHT?""; ""ENGAGING PATIENTS IN THE DECISION PROCESS""; ""EXTENDING ASSESSMENT TO ALL RELEVANT TREATMENT THEORIES""; ""THE EVALUATIVE CLINICAL SCIENCES AND THE FUTURE OF MEDICINE""; ""REFERENCES""; ""5 Strengths and Weaknesses of Health Insurance Data Systems for Assessing Outcomes""; ""STRENGTHS""; ""System-Wide, Population-Based Data""; ""Efficacy versus Effectiveness""; ""Large Numbers and Time Series""; ""Events Unaffected by Recall"" ""Unobtrusive Nature""""Multiple Comparisons""; ""Design Flexibility""; ""Potential for Multiple Projects""; ""Focus on Risks""; ""Clinical Decision Making""; ""WEAKNESSES""; ""Structural Limitations""; ""Bias Due to Reporting and Coding""; ""Bias Due to Differential Contact""; ""Benefits of Treatment""; ""CONTROVERSIAL AREAS""; ""Risk Adjustment""; ""Outcome Measures""; ""EXPANDING DATA BASES""; ""Record Linkage""; ""Primary Data Collection""; ""DISCUSSION""; ""REFERENCES""; ""6 Prescription-Event Monitoring: An Example of Total Population Post-Marketing Drug Surveillance "" """"THE NUMBERS GAME""""""VOLUNTARY REPORTING SYSTEMS""; ""POST-MARKETING SURVEILLANCE""; ""PRESCRIPTION-EVENT MONITORING""; ""COMPARATIVE STUDIES OF NSAIDS""; ""POST-MARKETING SURVEILLANCE AND POST-MARKETING CLINICAL TRIALS""; ""CONCLUSION""; ""REFERENCES""; ""7 The Role of Decision Analysis in the Translation of Research Findings into Clinical Practice ""; ""DECISION ANALYSIS AT THE INTERFACE BETWEEN CLINICAL INVESTIGATION AND CLINICAL PRACTICE""; ""WHAT DECISION ANALYSIS IS""; ""THE LIMITATIONS OF DECISION ANALYSIS: WHAT IT IS NOT"" ""SETTING PRIORITIES AND PARAMETERS FOR CLINICAL INVESTIGATION"" |
| Record Nr. | UNINA-9910957771403321 |
| Washington, D.C., : National Academy Press, 1990 | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
Sources of medical technology [[electronic resource] ] : universities and industry / / Nathan Rosenberg, Annetine C. Gelijns and Holly Dawkins, editors ; Committee on Technological Innovation in Medicine, Institute of Medicine
| Sources of medical technology [[electronic resource] ] : universities and industry / / Nathan Rosenberg, Annetine C. Gelijns and Holly Dawkins, editors ; Committee on Technological Innovation in Medicine, Institute of Medicine |
| Pubbl/distr/stampa | Washington, D.C., : National Academy Press, 1995 |
| Descrizione fisica | 1 online resource (254 p.) |
| Disciplina | 610/.72 |
| Altri autori (Persone) |
RosenbergNathan
GelijnsAnnetine DawkinsHolly V |
| Collana | Medical innovation at the crossroads |
| Soggetto topico |
Medical innovations
Medicine - Research |
| Soggetto genere / forma | Electronic books. |
| ISBN |
1-280-19318-2
9786610193189 0-309-58761-1 0-585-02173-2 |
| Formato | Materiale a stampa |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Record Nr. | UNINA-9910456249803321 |
| Washington, D.C., : National Academy Press, 1995 | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
